CXCL12/CXCR4 as a potential axis in diagnosis and predicting disease severity in COVID-19 patients: a new perspective

Ozkaya Alev Lazoğlu; Laloğlu Esra; Gul Albulhakim Hasan; Çelik Neslihan

doi:10.1515/tjb-2023-0193

Türk Biyokimya Dergisi (Jul 2024)

CXCL12/CXCR4 as a potential axis in diagnosis and predicting disease severity in COVID-19 patients: a new perspective

Ozkaya Alev Lazoğlu,
Laloğlu Esra,
Gul Albulhakim Hasan,
Çelik Neslihan

Affiliations

Ozkaya Alev Lazoğlu: Department of Biochemistry, Erzurum Regional Training and Research Hospital, Erzurum, Türkiye
Laloğlu Esra: Department of Biochemistry, Ataturk University School of Medicine, Erzurum, Türkiye
Gul Albulhakim Hasan: Department of Biochemistry, Ardahan State Hospital, Ardahan, Türkiye
Çelik Neslihan: Depertmant of Infection Diseases and Clinical Microbiology, Health Sciences University, Erzurum Regional Education and Research Hospital, Erzurum, Türkiye

DOI: https://doi.org/10.1515/tjb-2023-0193
Journal volume & issue: Vol. 49, no. 4
pp. 578 – 585

Abstract

Read online

Coronavirus disease 2019 (COVID-19) exhibits variations in terms of patients’ clinical symptoms and levels of routinely employed biochemical markers. The aim of the current study was to determine the correlation between serum levels of the C-X-C chemokine ligand type 12 (CXCL12) and C-X-C chemokine receptor type 4 (CXCR4), one of its specific receptors, and disease severity in COVID-19 patients.

Published in Türk Biyokimya Dergisi

ISSN: 1303-829X (Online)
Publisher: De Gruyter
Country of publisher: Germany
LCC subjects: Science: Chemistry: Organic chemistry: Biochemistry
Website: https://www.degruyter.com/journal/key/tjb/html

About the journal

Abstract

Keywords